Pharmafile Logo
Pharmafocus logo
Advanced Search

2seventy bio

Showing 1 posts of 1 posts found.

louis-reed-pwckf7l4-no-unsplash_5

Regeneron forms Regeneron Cell Medicines with acquisition of 2seventy bio

January 31, 2024
Business Services 2seventy bio, Pharmacy, Regeneron, Regeneron Cell Medicines, acquisition

Regeneron Pharmaceuticals has announced the formation of Regeneron Cell Medicines based on an agreement with 2seventy bio to acquire the …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026